UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050000
Receipt number R000056951
Scientific Title Effects of synbiotic yogurt on the intestinal function: An exploratory study
Date of disclosure of the study information 2023/01/12
Last modified on 2024/01/11 09:36:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of synbiotic yogurt on the intestinal function: An exploratory study

Acronym

Effects of synbiotic yogurt on the intestinal function: An exploratory study

Scientific Title

Effects of synbiotic yogurt on the intestinal function: An exploratory study

Scientific Title:Acronym

Effects of synbiotic yogurt on the intestinal function: An exploratory study

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of yogurt containing synbiotics on regulating the intestinal function for subjects with constipation tendency

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stool frequency, Fecal characteristics, Bowel movements, Abdominal symptoms

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of synbiotic yogurt for 4 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1) Subjects aged 18 years or older and younger than 75 years.
2) Subjects with a tendency for constipation (less than 5 times per week) or subjects who feel constipated themselves.

Key exclusion criteria

1) Subjects who regularly use drugs that affect bowel movements such as laxatives, medicine for intestinal disorders.
2) Subjects who regularly intake supplements containing Lactic acid bacteria, Bifidobacterium, oligosaccharide, and dietary fiber.
3) Subjects who have disease or serious medical history in liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolism, etc.
4) Subjects with medication allergy, food allergy, or serious history of these.
5) Subjects with milk allergy and lactose intolerance.
6) Subjects who are pregnant, under lactation or expecting to be pregnant during this study
7) Subjects who participated in other study within 1 month prior to obtaining informed consent, or those who are going to participate these study.
8) Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Kazunari
Middle name
Last name Tanaka

Organization

University of Nagasaki

Division name

Regional Partnership Center

Zip code

851-2195

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan

TEL

095-813-5216

Email

katanaka@sun.ac.jp


Public contact

Name of contact person

1st name Kanako
Middle name
Last name Imai

Organization

University of Nagasaki

Division name

Regional Partnership Center

Zip code

851-2195

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan

TEL

095-813-5500

Homepage URL


Email

kimai@sun.ac.jp


Sponsor or person

Institute

University of Nagasaki

Institute

Department

Personal name



Funding Source

Organization

Morinaga Milk Industry Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Nagasaki

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan

Tel

095-813-5216

Email

katanaka@sun.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 11 Month 29 Day

Date of IRB

2022 Year 12 Month 22 Day

Anticipated trial start date

2023 Year 01 Month 13 Day

Last follow-up date

2023 Year 03 Month 04 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 10 Day

Last modified on

2024 Year 01 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056951


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name